EUVIMED · CrossrefJournal
Expert Review of Hematology
ISSN 1747-4086 · Informa UK Limited
Latest articles
Managing poor graft function after stem cell transplantation
Risk of red blood cell transfusion in patients with preoperative anemia requiring cardiac surgery
Managing acute graft-versus-host disease after allogeneic stem cell transplantation
Complete remission in older acute myeloid leukemia: when does it really matter?
The evolving evidence ecosystem in chronic lymphocytic leukemia: from linear hierarchies to integrated synthesis
Progression-free survival prediction in diffuse large B-cell lymphoma: where can we further improve?
Treatment of older adults with newly diagnosed FLT3 -mutated AML: focus on lower-intensity triplet regimens
Shear wave elastography as a screening modality for liver fibrosis in a comprehensive sickle cell disease clinic
Managing thrombotic risk in myeloproliferative disorders
Implementation barriers of standardizing flow cytometric immune reconstitution monitoring post-allogeneic hematopoietic cell transplantation
Resistance mechanisms and therapeutic strategies after menin inhibitor failure in acute myeloid leukemia
Adaptations in pacritinib usage for myelofibrosis and thrombocytopenia since FDA approval
Rising myeloproliferative neoplasms in younger patients: preserving future fertility and pregnancies
Immunoglobulins as replacement therapy in hematological malignancies: from historical hypogammaglobulinemia to the era of T-cell-engaging therapies
Reframing sickle cell disease care: improving care with an embedded primary care model for chronic comorbidity management
Utilizing evidence-based diagnosis and treatment for central venous thrombosis: closing the gaps where guidelines fail
Ropeginterferon alfa-2b for adults with polycythemia vera: an updated perspective from approval to real-world clinical treatment
Diagnostic challenges in light chain (AL) amyloidosis for high-risk patients
The role of gene polymorphisms in the susceptibility and therapeutic response of chronic immune thrombocytopenic purpura
Frailty and chronic lymphocytic leukemia: navigating challenges to improve outcomes
Real-world treatment switching and sequencing to next line of therapy of zanubrutinib, acalabrutinib, and ibrutinib in chronic lymphocytic leukemia or small lymphocytic lymphoma
Beyond progression-free survival (PFS): time to next treatment (TTNT) as a patient-centered metric of clinical benefit in chronic lymphocytic leukemia (CLL)
Safety and efficacy of non-first-line drugs in the treatment of immune thrombocytopenia: a systematic review and network meta-analysis
Analysis of diagnostic value of lncRNA HCP5 in immune thrombocytopenia and its predictive value for disease progression
Current experiences with teclistamab in patients with multiple myeloma and renal impairment
Mucosal toxicity in hematological malignancies: prevention, management, and novel therapeutic insights
Circ_0035381 contributes to the progression of acute myeloid leukemia via regulating miR-186-5p/CDCA3 pathway
CD8+CD25+ Tregs as a predictor of glucocorticoid sensitivity in patients with immune thrombocytopenia
lncRNA GAS 5 rs145204276 as a risk factor for primary immune thrombocytopenia in the Chinese Han population
Key features of the underlying pathophysiology of Transfusion-related acute lung injury
EUVIMED